A doyen steps down :The Scientist [2009-06-01]


	The article you are attempting to read is Premium content which is only available to our online subscribers.

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today

	By Kerry Grens

A doyen steps down In the beginning of Audrey Evans's career spent researching neuroblastoma, the most common cancer in babies, almost every child diagnosed with the disease would die. By the time she retired last winter after 60 years, however, that had all changed.

A doyen steps down

In the beginning of Audrey Evans's career spent researching neuroblastoma, the most common cancer in babies, almost every child diagnosed with the disease would die. By the time she retired last winter after 60 years, however, that had all changed.